Concepedia

Gianni Chessari

GC

Statistics

Publications

30

Citations

3.4K

H-Index

27

Active since

1997

Affiliations

GW Pharmaceuticals (United Kingdom)(Current)

University of Sheffield

Cresset (United Kingdom)

Queen's University Belfast

Engineering and Physical Sciences Research Council

Gianni Chessari is an author at GW Pharmaceuticals (United Kingdom) specializing in drug discovery, medicinal chemistry, and pharmacy.

ORCID

Publications per year

1997–2024

30

Publications

30

Diverse, High-Quality Test Set for the Validation of Protein−Ligand Docking Performance

Michael J. Hartshorn, Marcel L. Verdonk, Gianni Chessari et al. · Journal of Medicinal Chemistry · 2007 · 642 citations

, , +16

Modeling Water Molecules in Protein−Ligand Docking Using GOLD

Marcel L. Verdonk, Gianni Chessari, Jason C. Cole et al. · Journal of Medicinal Chemistry · 2005 · 390 citations

, , +16

Discovery of (2,4-Dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a Novel Inhibitor of the Molecular Chaperone Hsp90 by Fragment Based Drug Design

Andrew Woodhead, Hayley C. Angove, Maria G. Carr et al. · Journal of Medicinal Chemistry · 2010 · 263 citations

, , +17

Application of Fragment-Based Lead Generation to the Discovery of Novel, Cyclic Amidine β-Secretase Inhibitors with Nanomolar Potency, Cellular Activity, and High Ligand Efficiency

Philip D. Edwards, Jeffrey S. Albert, Mark Sylvester et al. · Journal of Medicinal Chemistry · 2007 · 211 citations · Full text

, , +17

Fragment-Based Drug Discovery Applied to Hsp90. Discovery of Two Lead Series with High Ligand Efficiency

Christopher W. Murray, Maria G. Carr, Owen Callaghan et al. · Journal of Medicinal Chemistry · 2010 · 186 citations · Full text

, , +17

1–5 of 30